Table 1.
ψMLDA: the weights attributed by MLDA.
Gene name | Official Full Name | ψMLDA | p-value (Wilcoxon) | References: | |
1 | *MYLK | myosin light chain kinase | 0.14672 | 0.00000 | [24] |
2 | *KLK2 | kallikrein-related peptidase 2 | 0.12512 | 0.01053 | [49] |
3 | *KLK3 | kallikrein-related peptidase 3 | 0.12032 | 0.05625 | [50] |
4 | HAN11 | WD repeat domain 68 | 0.12019 | 0.00000 | |
5 | *LTF | lactotransferrin | 0.11594 | 0.00092 | [39] |
6 | CSRP1 | cysteine and glycine-rich protein 1 | 0.11355 | 0.00000 | [51] |
7 | *TGM4 | transglutaminase 4 (prostate) | 0.10452 | 0.06063 | [42] |
8 | *ACTG2 | actin gamma 2 smooth muscle enteric | 0.09826 | 0.00000 | [52] |
9 | MYL6 | myosin light chain 6 alkali smooth muscle and non-muscle | 0.09817 | 0.00045 | [53] |
10 | *RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.09583 | 0.00018 | [54] |
11 | *AZGP1 | alpha-2-glycoprotein 1 zinc-binding | 0.08817 | 0.00059 | [55] |
12 | NPAL3 | NIPA-like domain containing 3 | 0.08478 | 0.00008 | |
13 | PRO1073 | PRO1073 protein | 0.08077 | 0.28733 | |
14 | *FXYD3 | FXYD domain containing ion transport regulator 3 | 0.08024 | 0.05417 | [56] |
15 | TPM2 | tropomyosin 2 (beta) | 0.07919 | 0.00001 | [57] |
16 | CRYAB | crystallin alpha B | 0.07560 | 0.00000 | [58] |
17 | ACTA2 | actin alpha 2 smooth muscle aorta | 0.07372 | 0.01610 | [59] |
18 | *RPS6 | ribosomal protein S6 | 0.07323 | 0.12130 | [60] |
19 | TMEM130 | transmembrane protein 130 | 0.07296 | 0.00005 | |
20 | *ACPP | acid phosphatase prostate | 0.07185 | 0.00037 | [61] |
21 | *PCP4 | Purkinje cell protein 4 | 0.07128 | 0.00000 | [62] |
22 | *SYNPO2 | synaptopodin 2 | 0.06943 | 0.00000 | [63] |
23 | *SORBS1 | sorbin and SH3 domain containing 1 | 0.06773 | 0.00000 | [64] |
24 | *MSMB | microseminoprotein beta | 0.06588 | 0.00076 | [65] |
25 | ACTC | actin alpha cardiac muscle 1 | 0.06335 | 0.00001 | |
26 | *TGFB3 | transforming growth factor beta 3 | 0.06313 | 0.00000 | [66] |
27 | *MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.06205 | 0.14208 | [67] |
28 | ZNF532 | zinc finger protein 532 | 0.06131 | 0.00000 | |
29 | ANXA1 | annexin A1 | 0.06119 | 0.00001 | [68] |
30 | PALLD | palladin cytoskeletal associated protein | 0.06116 | 0.00000 | [69] |
31 | *MT2A | metallothionein 2A | 0.06054 | 0.00141 | [70] |
32 | ING5 | inhibitor of growth family member 5 | 0.05872 | 0.93009 | [71] |
33 | PGM5 | phosphoglucomutase 5 | 0.05862 | 0.00000 | |
34 | SERPINA3 | serpin peptidase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 3 | 0.05828 | 0.19710 | [72] |
35 | *KRT5 | keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types) | 0.05699 | 0.00000 | [73] |
36 | RPL5 | ribosomal protein L5 | 0.05589 | 0.53873 | [74] |
37 | *IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.05549 | 0.00000 | [75] |
38 | ZNF92 | zinc finger protein 92 (HTF12) | 0.05388 | 0.16056 | |
39 | *FOLH1 | folate hydrolase (prostate-specific membrane antigen) 1 | 0.05361 | 0.08683 | [76] |
40 | *CYR61 | cysteine-rich angiogenic inducer 61 | 0.05318 | 0.00020 | [77] |
41 | FHL1 | four and a half LIM domains 1 | 0.05305 | 0.00000 | [78] |
42 | *H19 | H19 imprinted maternally expressed transcript | 0.05221 | 0.00006 | [79] |
43 | DMN | desmuslin | 0.05219 | 0.00000 | |
44 | NEFH | neurofilament heavy polypeptide 200 kDa | 0.05186 | 0.00001 | [80] |
45 | PPP1R12B | protein phosphatase 1 regulatory (inhibitor) subunit 12B | 0.05149 | 0.00000 | |
46 | ANTXR2 | anthrax toxin receptor 2 | 0.05141 | 0.00002 | [81] |
47 | MRLC2 | myosin regulatory light chain MRLC2 | 0.05056 | 0.02204 | [82] |
48 | C20orf103 | chromosome 20 open reading frame 103 | 0.05055 | 0.00150 | |
49 | UBA52 | ubiquitin A-52 residue ribosomal protein fusion product 1 | 0.05033 | 0.00518 | [83] |
50 | TRGV9 | T cell receptor gamma variable 9 | 0.04983 | 0.00190 | |
51 | *SPARC | secreted protein acidic cysteine-rich (osteonectin) | 0.04969 | 0.00240 | [84] |
52 | *AMACR | alpha-methylacyl-CoA racemase | 0.04903 | 0.00011 | [85] |
53 | DNER | delta/notch-like EGF repeat containing | 0.04809 | 0.09301 | [86] |
54 | PRNP | prion protein (p27-30) | 0.04806 | 0.00000 | [87] |
55 | PDK4 | pyruvate dehydrogenase kinase isozyme 4 | 0.04751 | 0.00002 | [88] |
56 | *APOD | apolipoprotein D | 0.04744 | 0.12931 | [89] |
57 | *HERPUD1 | homocysteine-inducible endoplasmic reticulum stress-inducible ubiquitin-like domain member 1 | 0.04695 | 0.00001 | [90] |
58 | FSTL1 | follistatin-like 1 | 0.04692 | 0.00092 | [91] |
59 | HSPCB | heat shock protein 90 kDa alpha (cytosolic) class B member 1 | 0.04663 | 0.08386 | [92] |
60 | *GSTM2 | glutathione S-transferase M2 (muscle) | 0.04446 | 0.00000 | [93] |
61 | *PTN | pleiotrophin | 0.04440 | 0.00000 | [94] |
62 | *ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.04410 | 0.06528 | [95] |
63 | *CTGF | connective tissue growth factor | 0.04342 | 0.00004 | [96] |
64 | *GUCY1A3 | guanylate cyclase 1 soluble alpha 3 | 0.04303 | 0.05841 | [97] |
65 | MT1F | metallothionein 1F | 0.04303 | 0.00002 | [98] |
66 | *TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.04225 | 0.00000 | [99] |
67 | *LDHB | lactate dehydrogenase B | 0.04217 | 0.00000 | [100] |
68 | RNASE4 | ribonuclease RNase A family 4 | 0.04167 | 0.00000 | |
69 | ANPEP | alanyl aminopeptidase | 0.04165 | 0.00002 | [101] |
70 | *CAV1 | caveolin 1 caveolae protein 22 kDa | 0.04135 | 0.00000 | [102] |
71 | TM9SF2 | transmembrane 9 superfamily member 2 | 0.04122 | 0.01275 | |
72 | *HSPB8 | heat shock 22 kDa protein 8 | 0.04088 | 0.00000 | [103] |
73 | TUBA1A | tubulin alpha 1a | 0.04087 | 0.00018 | |
74 | PDLIM5 | PDZ and LIM domain 5 | 0.04077 | 0.32533 | [104] |
75 | LPP | LIM domain containing preferred translocation partner in lipoma | 0.04073 | 0.00003 | [105] |
76 | MAD2L1BP | MAD2L1 binding protein | 0.04051 | 0.62639 | [106] |
77 | *ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif 1 | 0.04048 | 0.00011 | [107] |
78 | *RHOA | ras homolog gene family member A | 0.04039 | 0.11368 | [108] |
79 | *TXNIP | thioredoxin interacting protein | 0.03995 | 0.00227 | [109] |
80 | OGDH | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) | 0.03974 | 0.07543 | |
81 | RPL35 | ribosomal protein L35 | 0.03971 | 0.17555 | |
82 | *ANKH | ankylosis progressive homolog (mouse) | 0.03856 | 0.00318 | [110] |
83 | MPST | mercaptopyruvate sulfurtransferase | 0.03856 | 0.00000 | [111] |
84 | MORF4L2 | mortality factor 4 like 2 | 0.03831 | 0.01337 | [112] |
85 | CRISPLD2 | cysteine-rich secretory protein LCCL domain containing 2 | 0.03799 | 0.00000 | |
86 | *CD9 | CD9 molecule | 0.03787 | 0.00150 | [113] |
87 | ALDH3A2 | aldehyde dehydrogenase 3 family member A2 | 0.03696 | 0.00001 | |
88 | SCN2B | sodium channel voltage-gated type II beta | 0.03693 | 0.00024 | [114] |
89 | *SPARCL1 | SPARC-like 1 (mast9 hevin) | 0.03693 | 0.00045 | [115] |
90 | IGJ | immunoglobulin J polypeptide linker protein for immunoglobulin alpha and mu polypeptides | 0.03683 | 0.00190 | [116] |
91 | ZNF134 | zinc finger protein 134 | 0.03670 | 0.00007 | |
92 | MRPL43 | mitochondrial ribosomal protein L43 | 0.03655 | 0.54934 | |
93 | LOC152485 | hypothetical protein LOC152485 | 0.03647 | 0.00000 | |
94 | CALM2 | calmodulin 2 (phosphorylase kinase delta) | 0.03622 | 0.05417 | [117] |
95 | COL9A2 | collagen type IX alpha 2 | 0.03546 | 0.00141 | |
96 | *PAGE4 | P antigen family member 4 (prostate associated) | 0.03541 | 0.00001 | [118] |
97 | CALM1 | calmodulin 1 (phosphorylase kinase delta) | 0.03536 | 0.00098 | [119] |
98 | *ACTB | actin beta | 0.03508 | 0.01159 | [120] |
99 | *AGR2 | anterior gradient homolog 2 (Xenopus laevis) | 0.03498 | 0.56006 | [121] |
100 | RPS28 | ribosomal protein S28 | 0.03497 | 0.15578 |
*: genes already described to be related to prostatic cancer. In bold are the genes which do not present statistical evidences to be differentially expressed between normal and tumoral conditions.